Drug class
Dopamine D2-receptor antagonist; substituted-benzamide antiemetic and prokinetic
Mechanism of action
Antagonises dopamine D2 receptors, including receptors in the chemoreceptor trigger zone, producing antiemetic activity; it also has prokinetic effects.
General use cases
- Nausea and vomiting
- Post-operative nausea and vomiting
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
